Goldfinch Bio
OverviewSuggest Edit
Goldfinch is singularly focused on discovering and developing precision therapies for patients with kidney disease.Chronic kidney disease is a driver of mortality across age, race, and stage of disease progression, affecting over 1 in 9 people worldwide. It has emerged as a global epidemic and growing problem that places an enormous social and economic burden on patients, their families, and society.Advances in kidney transplantation and dialysis over half a century ago extended life for patients with kidney failure, yet the current standard of care for patients with kidney disease remains inadequate, and there is an urgent need for new treatment options.Recent breakthroughs in genetics and biology have generated an unparalleled understanding of the biological pathways that drive kidney disease. Goldfinch is uniquely positioned to translate these discoveries into new therapies that target the molecular causes of kidney disease.
| Type | Private | |
| HQ | Cambridge, MA, US | Map |
| Website | goldfinchbio.com |
Latest Updates
| Cybersecurity rating | B | More |
Key People/Management at Goldfinch Bio
Anthony Johnson
Frank S. Czerwiec
Peter Mundel
Kyle Kuvalanka
Lori Rudolph-Owen
Jean-Christophe Harmange
Goldfinch Bio Office Locations
Goldfinch Bio Financials and Metrics
Summary Metrics
Goldfinch Bio total Funding | $155 m |
Goldfinch Bio latest funding size | $100 m |
Time since last funding | 7 months ago |
Goldfinch Bio investors | BlackRock, Ally Bridge Group, Casdin Capital, Gilead Sciences, Eventide Asset Management, Yonjin Capital, Wellington Management Company, Schroeder Adveq |
Goldfinch Bio Cybersecurity Score
Goldfinch Bio Online and Social Media Presence
Goldfinch Bio's Trends
Goldfinch Bio News and Updates
Gilead Sciences and Goldfinch Bio Announce Strategic Collaboration to Develop Novel Therapies for Kidney Disease
Gilead strikes deal with biotech Goldfinch Bio to tackle kidney diseases
Goldfinch Bio Frequently Asked Questions
Who are Goldfinch Bio key executives?
Goldfinch Bio's key executives are Anthony Johnson, Frank S. Czerwiec and Peter Mundel.
Who are Goldfinch Bio competitors?
Competitors of Goldfinch Bio include LGC, Principia BioPharma and Verona Pharma.
Where is Goldfinch Bio headquarters?
Goldfinch Bio headquarters is located at 215 First St 4th floor, Cambridge.
Where are Goldfinch Bio offices?
Goldfinch Bio has an office in Cambridge.
How many offices does Goldfinch Bio have?
Goldfinch Bio has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies